Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value
$5.51−0.26 (-4.51%)
Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –
Strata Critical Medical operating margin
Operating margin is operating income as a percentage of revenue.
Strata Critical Medical's operating margin for the twelve months ending Jun 30, 2026 was -8.0%. For fiscal 2025 it was -11.3%, against -15.3% the year before. The highest annual figure on record is -11.3% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -11.3% | +4.0 |
| FY2024 | Dec 31, 2024 | -15.3% | +14.9 |
| FY2023 | Dec 31, 2023 | -30.3% | +17.4 |
| FY2021 | Sep 30, 2021 | -47.7% | −3.5 |
| FY2020 | Sep 30, 2020 | -44.2% | −7.2 |
| FY2019 | Sep 30, 2019 | -37.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -7.5% | +2.8 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -4.4% | +11.4 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -9.6% | +6.6 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -11.4% | +8.3 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -10.3% | +7.6 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -15.8% | +3.3 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -16.2% | +58.8 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -19.7% | −9.2 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -17.9% | +2.1 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -19.2% | +9.2 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -75.1% | −27.2 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -10.4% | +32.5 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -20.0% | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -28.3% | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -47.9% | – |
| Q2 FY2020CQ1 2020 | Jun 30, 2020 | -42.9% | – |
See a number that looks wrong?